FDA is hoping payers will “do more” to share data on real-world outcomes of drugs, including cancer drugs, Commissioner Scott Gottlieb says.
The agency needs “help from industry, especially the payers, who sit on mountains of data that can inform the sort of real-world evidence that we’re increasingly dependent on as part...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?